Literature DB >> 27534815

Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.

Jiang Gu1, Qihan Chen1, Xiao Xiao2, Fumiaki Ito1, Aaron Wolfe2, Xiaojiang S Chen3.   

Abstract

APOBEC3H (A3H) is the most polymorphic member of the APOBEC3 family. Seven haplotypes (hap I-VII) and four mRNA splicing variants (SV) of A3H have been identified. The various haplotypes differ in anti-HIV activity, which is attributed to differences in protein stability, subcellular distribution, and/or RNA binding and virion packaging. Here, we report the first comparative biochemical studies of all the A3H variants using highly purified proteins. We show that all haplotypes were stably expressed and could be purified to homogeneity by Escherichia coli expression. Surprisingly, four out of the seven haplotypes showed high cytosine (C) deaminase activity, with hap V displaying extremely high activity that was comparable to the highly active A3A. Furthermore, all four haplotypes that were active in C deamination were also highly active on methylated C (mC), with hap II displaying almost equal deamination efficiency on both. The deamination activity of these A3H variants correlates well with their reported anti-HIV activity for the different haplotypes, suggesting that deaminase activity may be an important factor in determining their respective anti-HIV activities. Moreover, mC deamination of A3H displayed a strong preference for the sequence motif of T-mCpG-C/G, which may suggest a potential role in genomic mC modification at the characteristic "CpG" island motif.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  comparative in vitro functional studies; expression/purification of all APOBEC3H variants; mC deamination activity for mCpG; mC selectivity factor

Mesh:

Substances:

Year:  2016        PMID: 27534815      PMCID: PMC5529715          DOI: 10.1016/j.jmb.2016.08.012

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  57 in total

1.  APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese.

Authors:  Daisuke Sakurai; Yasumasa Iwatani; Hitoshi Ohtani; Taeko K Naruse; Hiroshi Terunuma; Wataru Sugiura; Akinori Kimura
Journal:  Immunogenetics       Date:  2015-02-27       Impact factor: 2.846

2.  Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.

Authors:  Lela Lackey; Emily K Law; William L Brown; Reuben S Harris
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

3.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

4.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

5.  Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.

Authors:  Ke Shi; Michael A Carpenter; Kayo Kurahashi; Reuben S Harris; Hideki Aihara
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

6.  Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA.

Authors:  Vincent Caval; Rodolphe Suspène; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  Mol Biol Evol       Date:  2013-10-25       Impact factor: 16.240

7.  HIV-1 Vif adaptation to human APOBEC3H haplotypes.

Authors:  Marcel Ooms; Bonnie Brayton; Michael Letko; Susan M Maio; Christopher D Pilcher; Frederick M Hecht; Jason D Barbour; Viviana Simon
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023

Review 8.  The AID/APOBEC family of nucleic acid mutators.

Authors:  Silvestro G Conticello
Journal:  Genome Biol       Date:  2008-06-17       Impact factor: 13.583

9.  Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.

Authors:  Mithun Mitra; Dustin Singer; Yu Mano; Jozef Hritz; Gabriel Nam; Robert J Gorelick; In-Ja L Byeon; Angela M Gronenborn; Yasumasa Iwatani; Judith G Levin
Journal:  Retrovirology       Date:  2015-01-22       Impact factor: 4.602

10.  The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population.

Authors:  Meng Zhu; Yuzhuo Wang; Cheng Wang; Wei Shen; Jia Liu; Liguo Geng; Yang Cheng; Juncheng Dai; Guangfu Jin; Hongxia Ma; Zhibin Hu; Hongbing Shen
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

View more
  15 in total

1.  Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.

Authors:  Fumiaki Ito; Yang Fu; Shen-Chi A Kao; Hanjing Yang; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2017-05-04       Impact factor: 5.469

2.  Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.

Authors:  Jennifer A Bohn; Justin DaSilva; Siarhei Kharytonchyk; Maria Mercedes; Jennifer Vosters; Alice Telesnitsky; Theodora Hatziioannou; Janet L Smith
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

3.  Molecular Interactions of a DNA Modifying Enzyme APOBEC3F Catalytic Domain with a Single-Stranded DNA.

Authors:  Yao Fang; Xiao Xiao; Shu-Xing Li; Aaron Wolfe; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2017-11-27       Impact factor: 5.469

4.  The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.

Authors:  Nadine M Shaban; Ke Shi; Kate V Lauer; Michael A Carpenter; Christopher M Richards; Daniel Salamango; Jiayi Wang; Michael W Lopresti; Surajit Banerjee; Rena Levin-Klein; William L Brown; Hideki Aihara; Reuben S Harris
Journal:  Mol Cell       Date:  2017-12-28       Impact factor: 17.970

5.  Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans.

Authors:  Zeli Zhang; Qinyong Gu; Marc de Manuel Montero; Ignacio G Bravo; Tomas Marques-Bonet; Dieter Häussinger; Carsten Münk
Journal:  PLoS Pathog       Date:  2017-12-21       Impact factor: 6.823

Review 6.  APOBEC3B, a molecular driver of mutagenesis in human cancers.

Authors:  Jun Zou; Chen Wang; Xiangyi Ma; Edward Wang; Guang Peng
Journal:  Cell Biosci       Date:  2017-05-30       Impact factor: 7.133

7.  Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.

Authors:  Xiao Xiao; Hanjing Yang; Vagan Arutiunian; Yao Fang; Guillaume Besse; Cherie Morimoto; Brett Zirkle; Xiaojiang S Chen
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

8.  Understanding the Structure, Multimerization, Subcellular Localization and mC Selectivity of a Genomic Mutator and Anti-HIV Factor APOBEC3H.

Authors:  Fumiaki Ito; Hanjing Yang; Xiao Xiao; Shu-Xing Li; Aaron Wolfe; Brett Zirkle; Vagan Arutiunian; Xiaojiang S Chen
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

9.  APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA.

Authors:  Jennifer A Bohn; Keyur Thummar; Ashley York; Alice Raymond; W Clay Brown; Paul D Bieniasz; Theodora Hatziioannou; Janet L Smith
Journal:  Nat Commun       Date:  2017-10-18       Impact factor: 14.919

10.  Association between APOBEC3H-Mediated Demethylation and Immune Landscape in Head and Neck Squamous Carcinoma.

Authors:  Qin Liu; Yue-Wen Luo; Ruo-Yan Cao; Xue Pan; Xi-Juan Chen; Si-Yuan Zhang; Wei-Lin Zhang; Jia-Ying Zhou; Bin Cheng; Xian-Yue Ren
Journal:  Biomed Res Int       Date:  2020-07-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.